OSSIO Raises $27.6 Million to Enhance Bio-Integrative Implants
Deal News | Dec 02, 2024 | Questa Capital Management LLC
OSSIO, a pioneer in orthopedic fixation technology, has successfully secured $27.6 million in equity funding led by Questa Capital, alongside existing investors. The capital infusion will enable OSSIO to accelerate its commercial capabilities, expand its product pipeline, and increase its reach in both the U.S. and selected international markets. Central to OSSIO's offering is the OSSIOfiber implant, which provides strong orthopedic fixation without leaving permanent materials in the body, thereby reducing the risk of post-surgical complications. With over 50,000 implants used since 2019, OSSIO is poised to expand its manufacturing and training facilities, driven by robust demand for its bio-integrative fixation technology. Questa Capital, known for backing healthcare expansion-stage companies, views OSSIO as a fitting addition to its portfolio. The firm will aid OSSIO in capitalizing on its technology's disruptive potential within the $16 billion orthopedic market. OSSIO is headquartered in Woburn, Massachusetts, and maintains R&D operations in Caesarea, Israel.
Sectors
- Healthcare
- Medical Devices
- Private Equity and Venture Capital
Geography
- United States – OSSIO is planning to expand its manufacturing and commercial facilities within the U.S., marking it as a key region for its market expansion efforts.
- Israel – OSSIO maintains its development headquarters in Caesarea, Israel, supporting its operations in bio-integrative fixation technology.
Industry
- Healthcare – The article centers around OSSIO, a medical device company, and discusses investments and advancements in orthopedic surgical implants focused on improving patient outcomes in healthcare.
- Medical Devices – OSSIO is developing and commercializing innovative bio-integrative surgical implants, which are a part of the medical devices sector.
- Private Equity and Venture Capital – Questa Capital's investment in OSSIO is a significant activity within private equity and venture capital realms, particularly in expansion-stage healthcare companies.
Financials
- $27.6 Million – The amount of equity funding raised by OSSIO to expand its commercial efforts and product pipeline.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| OSSIO, Inc. | Target Company | Company | A medical device company focused on orthopedic fixation technology using bio-integrative implants. |
| Questa Capital Management LLC | Investor | Company | A venture growth equity firm investing in expansion-stage healthcare companies. |
| MVM Partners | Investor | Company | An existing investor participating in the latest funding round for OSSIO. |
| OCV | Investor | Company | An existing investor participating in the latest funding round for OSSIO. |
| Ortho-Vision | Investor | Company | An existing investor participating in the latest funding round for OSSIO. |
| Courage Capital | Investor | Company | An existing investor participating in the latest funding round for OSSIO. |